期刊文献+

肝胆管结石合并肝胆管癌的临床分析 被引量:2

Clinical Analysis of Hepatolithiasis with Hepato-Cholangiocarcinoma
原文传递
导出
摘要 目的:探讨肝胆管结石合并胆管癌的临床表现特征和诊治经验。方法:分析了自2001年1月到2009年8月我院收治的30例肝胆管结石合并胆管癌患者的临床资料。结果:肝胆管结石合并胆管癌术前确诊10例,术中病理检查确诊14例,术后病理检查发现6例。左肝胆管癌16例,占53.3%,右肝胆管癌7例占23.3%,肝门部胆管癌5例占16.7%,其余2例为左右肝都有。肿瘤根治性切除术17例(56.7%),姑息性手术9例(30%),单纯活检4例(13.3%)。在30例随访资料中,根治性切除术者平均存活时间26个月。存活1年以上10例,2年以上5例,3年以上2例;姑息治疗者术后平均生存9个月;其余的≤4个月。结论:胆石症状易反复发作,胆道病史较长大于10年且术前CA199>2500 ng/mL的患者应高度怀疑合并有胆管癌。 Objective: To analysis the clinical characteristics,diagnosis,and treatment of cholelithiasis complicated with cholangiocaminoma.Methods: Clinical and pathological data were analysed retrospectively on 30 cases of hepatolithiasis complicated with cholangiocarcinoma.Results: Ten(33%) patients of patients were diagnosed as cholangiocarcinoma preoperatively.Tumor occurring in left intrahepatic ducts,right intrahepatic ducts,and hilar bile duct was 53.3%,23.3% and 16.7% respectively.Other two cases are in both left and right hepatic lobes.17(56.7%) cases underwent radical resection,and their mean survival time was 26 months;9(30%) cases underwent palliative operation,and their mean survival time was 9 months;Other 4 cases were under no surgical treatment whose survival time was less than 4 months.Conclusion: The symptom of hepatolithiasis appears repeatedly.If patients with a history of hepatolithiasis more than 10 years and their preoperative CA199 was more than 2500 ng/mL are under the risk of cholangiocareinoma.
作者 汤万荣
出处 《华西医学》 CAS 2010年第1期129-131,共3页 West China Medical Journal
关键词 胆结石 胆管癌 cholelithiasis cholangiocarcinoma
  • 相关文献

参考文献7

  • 1SANES S, MAC CALIUM JD. Primary carcinoma of the liver cholangioma in hepatolithiasis [J].Pathol, 1952, 18(7): 675. 被引量:1
  • 2黄志强.肝内胆管结石与肝胆管癌[J].中华外科杂志,1981,19:403-404. 被引量:19
  • 3苏逢锡,陈积圣,曾韵洁.肝内胆管结石合并肝内胆管癌[J].普外临床,1995,10(6):338-340. 被引量:24
  • 4王友顺,黄宗海,姜宏.肝胆管结石合并肝胆管癌的诊断与治疗(附45例报告)[J].中国实用外科杂志,1997,17(9):544-545. 被引量:17
  • 5NAKEEB A, I.IPSETR PA, LILEMOC KD,et al. Biliary carcino embryonic antigen levels are a marker for cholangiocarcinoma[J]. AmJ Surg,1996,171:147- 153. 被引量:1
  • 6CHEN CY,SHIESH SC,TSAO HC,et al. The assessment of bili ary CA125, CA1929 and CEA in diagnosing cholangiocarcinoma the influence of sampling time and hepotolithiasis[J].Hepatogastroen terology,2002,49: 616-620. 被引量:1
  • 7KIM YT, BYUN JS, KIM J, et al. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis[J]. Hepatogastroen lerology,2003,50:8 -12. 被引量:1

二级参考文献1

共引文献52

同被引文献15

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部